Glasdegib,Gemtuzumab Ozogamicin
Pfizer
['leusm', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)']
congress | #eha2023 nigel russell, highlights results from the ncri aml19 trial. flag-ida-go improved os and reduced the number of patients who were mrd+ vs da-go in patients with npm1 mutated aml. the os benefit was independent of flt3 mutational and mrd status. #leusm 
The AML Hub is an evidence-based online resource on Acute Myeloid Leukemia (AML), for academic researchers and treating clinicians. #leusm